Brian Casey, Kate Madden Yee, Wayne Forrest, Erik L. Ridley, and Eric Barnes

2016
Top 5 trends from RSNA 2016 in Chicago
With McCormick Place in the rearview mirror, it's always useful to take a look back at radiology's showcase conference for signs of trends to come in medical imaging.
December 14, 2016
2016 12 14 17 05 10 15 Rsna 2016 Hall Opener 400
2015
Top 5 trends from RSNA 2015 in Chicago
It's always a challenge to encapsulate an extravaganza as sprawling as the RSNA conference into neat little compartments. The fable of the blind men trying to describe an elephant comes to mind -- an apt analogy for trying to get a handle on a six-day tour de force that often leaves attendees exhausted and overwhelmed.
December 9, 2015
2015 12 09 16 24 33 462 Rsna 2015 Theme 200
Breast
Top 5 trends from RSNA 2014 in Chicago
With RSNA 2014 in the books, now is a good time to look back on the Chicago meeting to identify the major trends affecting radiology. Top stories circulating the halls of McCormick Place included the meeting's 100th anniversary, as well as CT lung cancer screening and the rise of enterprise imaging.
December 10, 2014
2014 12 10 16 16 15 362 Rsna Breezeway 200
Page 1 of 1
Top Stories
(A,B) Images from an initial ultrasound examination showed no identifiable lesions and received a consensus ultrasound category of US-1. Nearly the entire liver is visualized, with minimal shadowing (“s”, A and B), and the examination received consensus result of VIS-A. The AFP level was 7.1 ng/mL on assessment six months before the ultrasound, 9.1 ng/mL on assessment three months before examination, and 14.2 ng/mL on assessment on exam day. The AFP result was thus assessed as positive based on a progressive increase on two consecutive tests. The atient was considered to have negative surveillance result according to LI-RADS Ultrasound Surveillance v2017, but positive surveillance result according to LI-RADS Ultrasound Surveillance v2024. (C-D) Axial arterial-phase (C) and portal-venous phase (D) T1-weighted images from subsequent gadoxetic acid-enhanced MRI show a 2-cm arterial-phase hyperenhancing observation (arrow, C) with portal-venous washout (arrow, D) in segment 7. This observation was classified on MRI as LR-5, thus meeting the present study’s reference standard for diagnosis of HCC. The mass is located in the periphery of the liver, an anatomic area where ultrasound visualization can be challenging due to shadowing.
Ultrasound
LI-RADS ultrasound surveillance version 2024 improves HCC detection
The 2024 version of the LI-RADS Ultrasound Surveillance system improves detection of hepatocellular carcinoma (HCC) over earlier iterations.
Lung Ct Images
CT
Deep learning helps find, segment lung tumors on CT imaging
Images in a 74-year-old male patient who presented at the hospital with acute symptoms of a right hemispheric ischemic stroke and a National Institutes of Health Stroke Scale (NIHSS) score of 24. (A) Nonenhanced CT image shows no signs of early infarction, whereas (B) CT perfusion image shows a large perfusion deficit in the territory of the middle cerebral artery and anterior cerebral artery caused by an extracranial occlusion in the right internal carotid artery. (C) Digital subtraction angiography shows the occlusion in the C1 segment. The extracranial occlusion was passed, reperfused, and subsequently stented (D, E). The final contrast injection did not reveal any intracranial occlusions within the territory of the internal carotid artery (F). At the 24-hour follow-up, there was no infarction on (G) the nonenhanced CT image, and the NIHSS score had decreased to 3 points. Image courtesy of RSNA.
Interventional
EVT promising in patients with extracranial ICA occlusions
Images depict a 49-year-old female participant with cryptogenic cirrhosis who presented with a 3.2-cm liver lesion. This biopsy-confirmed hepatocellular carcinoma (HCC) with an initial categorization of Liver Imaging Reporting and Data System (LI-RADS) category LR-4 (probably HCC) at CT was upgraded to LR-5 (definitely HCC) at contrast-enhanced ultrasound (CEUS). (A) Precontrast CT images in the liver show vague hypoattenuation in the medial left hepatic lobe (arrows). (B) Arterial phase images demonstrate no definite arterial phase hyperenhancement (arrows). (C) Washout and an enhancing capsule (arrows) on a late-phase image resulted in an LR-4 categorization. (D) B-mode ultrasound shows a round hypoechoic nodule (arrows). (E) An early-phase CEUS image shows clear arterial-phase hyperenhancement (arrows); (F) No washout at one minute (arrows), and (G) late, mild washout at four minutes (arrows) resulted in a CEUS LR-5 categorization.
Ultrasound
CEUS resolves indeterminate CT, MRI liver observations
Ctca
Molecular Imaging
PET/CT can rule out CAV in heart transplant patients
More in Home
LI-RADS ultrasound surveillance version 2024 improves HCC detection
By Amerigo Allegretto
The 2024 version of the LI-RADS Ultrasound Surveillance system improves detection of hepatocellular carcinoma (HCC) over earlier iterations.
January 22, 2025
(A,B) Images from an initial ultrasound examination showed no identifiable lesions and received a consensus ultrasound category of US-1. Nearly the entire liver is visualized, with minimal shadowing (“s”, A and B), and the examination received consensus result of VIS-A. The AFP level was 7.1 ng/mL on assessment six months before the ultrasound, 9.1 ng/mL on assessment three months before examination, and 14.2 ng/mL on assessment on exam day. The AFP result was thus assessed as positive based on a progressive increase on two consecutive tests. The atient was considered to have negative surveillance result according to LI-RADS Ultrasound Surveillance v2017, but positive surveillance result according to LI-RADS Ultrasound Surveillance v2024. (C-D) Axial arterial-phase (C) and portal-venous phase (D) T1-weighted images from subsequent gadoxetic acid-enhanced MRI show a 2-cm arterial-phase hyperenhancing observation (arrow, C) with portal-venous washout (arrow, D) in segment 7. This observation was classified on MRI as LR-5, thus meeting the present study’s reference standard for diagnosis of HCC. The mass is located in the periphery of the liver, an anatomic area where ultrasound visualization can be challenging due to shadowing.
Deep learning helps find, segment lung tumors on CT imaging
By Kate Madden Yee
Using a deep-learning model with lung CT imaging shows promise for identifying and segmenting tumors, researchers have reported.
January 22, 2025
Lung Ct Images
EVT promising in patients with extracranial ICA occlusions
By Will Morton
Endovascular thrombectomy (EVT) and best medical treatment are both effective and safe options for patients with acute extracranial internal carotid artery occlusions.
January 21, 2025
Images in a 74-year-old male patient who presented at the hospital with acute symptoms of a right hemispheric ischemic stroke and a National Institutes of Health Stroke Scale (NIHSS) score of 24. (A) Nonenhanced CT image shows no signs of early infarction, whereas (B) CT perfusion image shows a large perfusion deficit in the territory of the middle cerebral artery and anterior cerebral artery caused by an extracranial occlusion in the right internal carotid artery. (C) Digital subtraction angiography shows the occlusion in the C1 segment. The extracranial occlusion was passed, reperfused, and subsequently stented (D, E). The final contrast injection did not reveal any intracranial occlusions within the territory of the internal carotid artery (F). At the 24-hour follow-up, there was no infarction on (G) the nonenhanced CT image, and the NIHSS score had decreased to 3 points. Image courtesy of RSNA.
CEUS resolves indeterminate CT, MRI liver observations
By Amerigo Allegretto
Contrast-enhanced ultrasound (CEUS) can resolve some high-risk indeterminate liver observations initially seen on CT or MRI.
January 21, 2025
Images depict a 49-year-old female participant with cryptogenic cirrhosis who presented with a 3.2-cm liver lesion. This biopsy-confirmed hepatocellular carcinoma (HCC) with an initial categorization of Liver Imaging Reporting and Data System (LI-RADS) category LR-4 (probably HCC) at CT was upgraded to LR-5 (definitely HCC) at contrast-enhanced ultrasound (CEUS). (A) Precontrast CT images in the liver show vague hypoattenuation in the medial left hepatic lobe (arrows). (B) Arterial phase images demonstrate no definite arterial phase hyperenhancement (arrows). (C) Washout and an enhancing capsule (arrows) on a late-phase image resulted in an LR-4 categorization. (D) B-mode ultrasound shows a round hypoechoic nodule (arrows). (E) An early-phase CEUS image shows clear arterial-phase hyperenhancement (arrows); (F) No washout at one minute (arrows), and (G) late, mild washout at four minutes (arrows) resulted in a CEUS LR-5 categorization.
PET/CT can rule out CAV in heart transplant patients
By Will Morton
Cardiac PET/CT scans can effectively rule out moderate to severe cardiac allograft vasculopathy (CAV) in heart transplant patients.
January 17, 2025
Ctca
Machine learning can predict immunotherapy response in NSCLC patients
By Kate Madden Yee
Machine learning (ML) can help clinicians predict immunotherapy response in patients with inoperable non-small cell lung cancer (NSCLC).
January 17, 2025
Lung Ct Images
Current topics in mammography
By Sandy Coffta
Sandy Coffta of Healthcare Administrative Partners discusses changes in reporting and reimbursement for mammography exams.
January 17, 2025
Coffta Sandy Thumbnail
Surgeon General's alcohol advisory puts patient counseling at the fore
By Amerigo Allegretto
Patient communication and education may be key for radiologists in the wake of the Surgeon General’s advisory on alcohol-related cancer risk.
January 17, 2025
Wine Red Glass 400
FAPI-PET shows promise for imaging gastric cancers
By Will Morton
Gallium-68 fibroblast activation protein inhibitor (FAPI) PET/CT is a promising new method for imaging gastric cancer.
January 16, 2025
Fapi Pet Gastric Cancer Thumbnail
CEM has slightly higher mean glandular dose than DBT, mammography
By Amerigo Allegretto
Contrast-enhanced mammography (CEM) has a slightly higher mean glandular dose than other breast imaging modalities.
January 16, 2025
Contrast Injector
ACS: Cancer mortality continues to drop
By Kate Madden Yee
Cancer mortality rates continue to drop -- although incidence of the disease is rising in women, according to an annual study released by the ACS.
January 16, 2025
Cancer Cell Target2
POCUS useful for diagnosis of retained conception tissue
By Amerigo Allegretto
Point-of-care ultrasound (POCUS) can be a useful tool for diagnosing the presence of retained conception tissue.
January 15, 2025
Ultrasound Portable
Page 1 of 111
Next Page